PDA

View Full Version : Neostem Inc.


  1. Neuralstem Inc. President and CEO Publishes New Blog Entitled ''O brave new ... - MarketWatch (press release)
  2. Neuralstem, Inc. (NYSEMKT:CUR) Down 3.12%, TransAtlantic Petroleum Ltd ... - GSPInsider
  3. NEURALSTEM, INC. : Neuralstem ALS Trial Principal Investigator, Dr. Eva ... - 4-traders (press release)
  4. NeoStem, Inc. Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001
  5. NeoStem to Present at Multiple Conferences in May
  6. NEURALSTEM, INC. : Neuralstem Principal Investigator, Dr. Eva Feldman ... - 4-traders (press release)
  7. NEURALSTEM, INC. : Neuralstem Reports First Quarter Financial Results And ... - 4-traders (press release)
  8. Stocks Closing Higher Today: Neuralstem Inc. (NYSEMKT:CUR), Tranzyme Inc ... - NIS
  9. NeoStem, Inc. Clarification: No New Securities Being Issued
  10. Neuralstem ALS Trial Investigator And Patient On Sirius XM - PR Newswire (press release)
  11. NeoStem Announces Closing of Public Offering of Common Stock
  12. NEURALSTEM, INC. : Neuralstem ALS Trial Investigator And Patient On Sirius XM - 4-traders (press release)
  13. NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Enters Into a Services Agreement With Sentien Biotechnologies, Inc.
  14. Stocks Buzz: McEwen Mining Inc, Neuralstem, LDK Solar Co, Randgold ... - SBWire (press release)
  15. NEURALSTEM, INC. : Neuralstem And The National Football League Alumni ... - 4-traders (press release)
  16. NEURALSTEM, INC. : FDA Approves Neuralstem To Treat Final Cohort In NSI ... - 4-traders (press release)
  17. Neuralstem (CUR): FDA OKs Mid-Stage Stem Cell Trial For Lou Gehrig's Disease - iStockAnalyst (press release)
  18. NEURALSTEM, INC. : Neuralstem Receives FDA Approval To Commence ... - 4-traders (press release)
  19. NEURALSTEM, INC. : Neuralstem Receives Notice Of Allowance Of Patent ... - 4-traders (press release)
  20. NeoStem, Inc. to Present at Multiple Conferences in April
  21. NeoStem, Inc. Awarded Second Year of National Institute of Allergy And Infectious Diseases (NIAID) Research Grant for the Development of VSEL Technology for Radiation Exposure
  22. HERCULES TECHNOLOGY GROWTH CAPITAL INC : Neuralstem Secures $8 ... - 4-traders (press release)
  23. CEO Robin Smith on Bloomberg Taking Stock
  24. Notable AMEX Stocks: Neuralstem, Uranium Energy Corp, VirnetX Holding ... - SBWire (press release)
  25. Hot Stocks Roundup: PHI Inc (NASDAQ:PHII), Neuralstem (NYSE:CUR) - eStocksDaily
  26. NEURALSTEM, INC. : Neuralstem CEO, Richard Garr, Named To "Top 50 Global ... - 4-traders (press release)
  27. NeoStem, Inc. Announces Intellectual Property Expansion in Cardiovascular Disease
  28. Sistemic Ltd and Leading CDMO, Progenitor Cell Therapy Initiate Study on Novel Stem Cell Characterisation Technology
  29. Stocks up for the Day: Axiologic Inc (PINK:AXLX), Neuralstem Inc. (NYSEAMEX ... - NIS
  30. NeoStem, Inc. Reports Second Data Safety Monitoring Board Review: Continue With PreSERVE AMI Phase 2 Trial as Planned
  31. Healthcare Stocks Buzz: Neuralstem, Bacterin International Holdings Inc ... - SBWire (press release)
  32. NEURALSTEM, INC. : Neuralstem Grants Licenses For Central Nervous System ... - 4-traders (press release)
  33. NEURALSTEM, INC. : Neuralstem President And CEO To Present At BIO CEO ... - 4-traders (press release)
  34. RedChip Money Report with Dave Gentry (Fox Business): Episode 12
  35. NeoStem, Inc. Announces Further Expansion of Intellectual Property Coverage
  36. Notable Gainers: United Parcel Service, Inc.(NYSE:UPS), Neuralstem, Inc ... - Mesh Press (press release)
  37. NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Enters Into a Cell Therapy Manufacturing Services Agreement With Adaptimmune Ltd.
  38. MarketExclusive: Neuralstem Inc. - What the FDA's Approval Really Means for ... - MarketWatch (press release)
  39. NeoStem, Inc. Announces Receipt of Hellman Research Award by Academic Collaborator for VSEL™ Research
  40. NeoStem, Inc. Announces Research Supporting VSEL(TM) Technology Presented at the American Society of Hematology Annual Meeting
  41. NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, and Hackensack University Medical Center Enter Into a Cell Processing and Storage Services Agreement
  42. NEURALSTEM, INC. : Neuralstem President and CEO to Present 2013 Trials ... - 4-traders
  43. NeoStem, Inc. to Present at Multiple Conferences in January
  44. NEURALSTEM, INC. : Neuralstem Investigator Presents New ALS NSI-566 Data ... - 4-traders
  45. Neuralstem Investigator Presents New ALS NSI-566 Data at International ... - Sacramento Bee
  46. Recent Animal Based Studies May Further Validate the Potential of Cell Therapy ... - Market Playground
  47. Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases - Marketwire (press release)
  48. Stem Cells Save Teeth
  49. NeoStem, Inc. Ranked Number 1 Fastest Growing Company in the Tri-State Region on Deloitte & Touche LLP (New York, New York)'s 2012 Technology Fast 500™
  50. NeoStem, Inc. Closes Divestiture of Its Ownership Interest in Suzhou Erye Pharmaceuticals Company Ltd.
  51. Neuralstem Reports Third Quarter Financial Results And Provides Update On ... - The Herald | HeraldOnline.com
  52. Neuralstem Reports Third Quarter Financial Results And Provides Update On ... - Equities.com
  53. Neuralstem Reports Third Quarter Financial Results And Provides Update On ... - Sacramento Bee
  54. Lots of new presentations for Neostem
  55. FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In ... - The Herald | HeraldOnline.com
  56. Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive ... - News-Medical.net
  57. Neuralstem begins dosing second cohort of patients in NSI-189 phase Ib trial ... - pharmabiz.com
  58. Neuralstem gets FDA okay for depression study - MarketWatch
  59. FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In ... - Sacramento Bee
  60. Significant Recovery Of Motor And Neurological Functions In Ischemic Stroke ... - Sacramento Bee
  61. Neuralstem To Present Preclinical Data At Neuroscience 2012, 42nd Annual ... - Sacramento Bee
  62. Neuralstem To Present Preclinical Data At Neuroscience 2012, 42nd Annual ... - The Herald | HeraldOnline.com
  63. Dr. Eva Feldman, Principal Investigator, Updates Interim Data On Completed ... - Equities.com
  64. Dr. Eva Feldman, Principal Investigator, To Update Interim Data On Neuralstem ... - Sacramento Bee
  65. Dr. Eva Feldman, Principal Investigator, To Update Interim Data On Neuralstem ... - The Herald | HeraldOnline.com
  66. What Next For Neuralstem? - Seeking Alpha
  67. Neuralstem Approved To Commence Ischemic Stroke Trial In China - Sacramento Bee
  68. NEURALSTEM, INC. : Neuralstem Approved To Commence Ischemic Stroke ... - 4-traders
  69. Neuralstem President And CEO To Present At The 2012 Aegis Healthcare ... - Sacramento Bee
  70. NEURALSTEM, INC. : Neuralstem President And CEO To Present At The 2012 ... - 4-traders
  71. Neuralstem Announces Closing of $7 Million Registered Direct Offering - Sacramento Bee
  72. NEURALSTEM, INC. : Neuralstem Announces Closing of $7 Million Registered ... - 4-traders
  73. Biotech Roundup: OXGN, JAZZ, CUR, ONXX in Focus - SmallCap Network
  74. Neuralstem Inc. (CUR) Jumping the Gun or Fast and Furious? - Proactive Investors USA & Canada
  75. Biotechnology Stock in Focus; Neuralstem Inc. (CUR) - SmallCap Network
  76. NEURALSTEM, INC. : Neuralstem Announces Proposed Public Offering - 4-traders
  77. Neuralstem CSO, Dr. Karl Johe, To Speak At 6th Neurodegenerative Conditions ... - Sacramento Bee
  78. Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw ... - Sacramento Bee
  79. NEURALSTEM, INC. : Neuralstem President And CEO To Present At The 2012 ... - 4-traders
  80. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices - Sacramento Bee
  81. NEURALSTEM, INC. : Neuralstem Grants First Licenses For CNS Therapy ... - 4-traders
  82. Paralyzed patients regain some sensory function after neural stem cell treatment - CBS News
  83. StemCells, Inc. Reports Positive Interim Data From Spinal Cord Injury Trial - NASDAQ
  84. Nokia Corporation Breaks 3-Day losing Streaks (NOK, CUR, CRME, TC, NAV) - The Markets Are Open (blog)
  85. Neuralstem Completes Phase I ALS Stem Cell Trial - RedOrbit
  86. Neuralstem Completes Phase I ALS Stem Cell Trial - Sacramento Bee
  87. NEURALSTEM, INC. : Neuralstem Announces Exercise Of Entire Over-Allotment ... - 4-traders
  88. Neostem (NBS) files a secondary offering
  89. Equity Briefing: Upgrades and Downgrades for August 23rd: CS, CUR, DLLR ... - Bioscience Technology
  90. Equity Briefing: Upgrades and Downgrades for August 23rd: CS, CUR, DLLR ... - Reuters
  91. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis ... - Sacramento Bee
  92. Neuralstem Announces Pricing Of Public Offering Of 6000000 Shares Of ... - Sacramento Bee
  93. NEURALSTEM, INC. : Neuralstem Announces Pricing Of Public Offering Of ... - 4-traders
  94. NEURALSTEM, INC. : Neuralstem Reports Second Quarter Financial Results ... - 4-traders
  95. Neuralstem Reports Second Quarter Financial Results And Provides Clinical ... - Sacramento Bee
  96. Who would have thought?
  97. StemCells, Inc. Broadens HuCNS-SC(R) Patent Portfolio With Key Patent in Japan - MarketWatch (press release)
  98. Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural ... - MarketWatch (press release)
  99. Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural ... - Sacramento Bee
  100. Neostem on Seeking Alpha
  101. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial - Sacramento Bee
  102. Neuralstem Inc announces dosing of 17th patient in ALS stem cell trial - MENAFN.COM
  103. NEURALSTEM, INC. : Seventeenth Patient Dosed in Neuralstem ALS Stem Cell ... - 4-traders
  104. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific ... - Sacramento Bee
  105. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific ... - PR Newswire (press release)
  106. Neostem Travis Johnson / Stock Gumshoe
  107. StemCells, Inc. Announces Its Human Neural Stem Cells Restore Memory in ... - MarketWatch (press release)
  108. Stock Analysts' New Coverage for July 12th: AMZN, CMA, CUR, EMC, IBM, IMPV ... - MarketWatch (press release)
  109. Equity Briefing: Stock Analysts' New Coverage for July 11th: AMZN, CMA, CUR ... - MarketWatch (press release)
  110. WBB Securities Upgrades Neostem to Strong-Buy (NBS)
  111. Russell Rebalancing Leaves NeoStem Trading Higher To Reflect Good News
  112. Alert, no story yet
  113. Global Stem Cell Research Industry - Sacramento Bee
  114. Neostem HUGE news, to sell 51% stake in Suzhou for 12.3 million
  115. Baltimore Tuesday Stock Wrap - Citybizlist (press release)
  116. Dr. Robin Smith Explaining NeoStem: A True Value Play
  117. StemCells, Inc. Reports Positive Interim Safety Data From Spinal Cord Injury Trial - MarketWatch (press release)
  118. BioRestorative (BRTX): Two Huge Markets, One Solid Business Model - BiotechStockTrader.com
  119. neostem ceo on bloomberg right now..
  120. 5 Reasons To Buy NeoStem And 2 Catalysts
  121. Neuralstem Reports First Quarter Financial Results And Provides Business And ... - MarketWatch (press release)
  122. Rebounding?
  123. NeoStem: Huge Potential In The Cell Therapy Sector
  124. StemCells rare disease trial nets early positive results - Bizjournals.com (blog)
  125. StemCells, Inc's Milestone Clinical Trial in Pelizaeus-Merzbacher Disease ... - MarketWatch (press release)
  126. NEURALSTEM ANNOUNCES 2011 FINANCIAL RESULTS, PROVIDES OPERATIONS UPDATE - MarketWatch (press release)
  127. NEURALSTEM ANNOUNCES 2011 FINANCIAL RESULTS, PROVIDES OPERATIONS UPDATE - Reuters
  128. NeoStem Announces Proposed Public Offering of Common Stock and Warrants
  129. Neuralstem ALS Stem Cell Trial Interim Results Reported in the Journal, STEM CELLS - Sacramento Bee
  130. STEMCELLS INC : StemCells, Inc. Reports Fourth Quarter and Year End 2011 ... - 4-traders
  131. StemCells, Inc. Reports Fourth Quarter and Year End 2011 Financial Results and ... - GlobeNewsWire (press release)
  132. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial - MarketWatch (press release)
  133. Baltimore Tuesday Stock Wrap - Citybizlist (press release)
  134. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial - Bradenton Herald
  135. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial - Sacramento Bee
  136. Exciting Progress in Commercialization of Stem Cell Therapies - Institute for Ethics and Emerging Technologies
  137. NEURALSTEM, INC. : Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial - 4-traders
  138. Neuralstem Shows Solid Progress in Spinal Cord Neural Stem Cell Trial for ALS - MarketWatch (press release)
  139. Baltimore Friday Stock Wrap - Citybizlist (press release)
  140. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering - MarketWatch (press release)
  141. Baltimore Wednesday Stock Wrap - Citybizlist (press release)
  142. StemCells, Inc. to Present at the 24th Annual Roth Growth OC Conference - MarketWatch (press release)
  143. Baltimore Wednesday Stock Wrap - Citybizlist (press release)
  144. Will StemCells Walk The Talk? - RTT News
  145. StemCells, Inc. Announces Webcast to Discuss 2011 Financial Results and ... - MarketWatch (press release)
  146. NeoStem’s PCT unit named manufacturer in Baxter phase III stem cell trial
  147. Addressing the Unmet Needs of AMI Patients
  148. Islet Sciences, Inc. Selects NeoStem’s Manufacturing
  149. NeoStem’s CEO Letter to Shareholders
  150. Neostem's Amorcyte featured on CBS news
  151. Shares of Neostem Fall Below Previous 52-Week Low
  152. Recent 52-Week Low Surpassed in Shares of Neostem (NBS)
  153. A visit to the Vatican
  154. CEO Robin Smith @ the Vatican on Video
  155. Vatican signs deal to collaborate on adult stem cell research
  156. NeoStem Closes on Amorcyte Acquisition
  157. Vatican Stem Cell Endeavor with US Company in Full Swing
  158. NeoStem’s PCT subsidiary signs manufacturing agreement with ImmunoCellular
  159. NeoStem Announces Participation in Multiple October Conferences
  160. NeoStem's Subsidiary, Progenitor Cell Therapy, and ImmunoCellular Therapeutics Enter Into a Manufacturing Agreement
  161. Which? Neostem or Neuralstem?
  162. NeoStem Announces Change in Presentation Time for JMP Securities Conference
  163. Neuralstem Receives Russian Patent
  164. Big Jump Today
  165. Neuralstem Updates ALS Clinical Trial Progress
  166. Neuralstem Reports First Quarter Financial Results
  167. Neuralstem ALS Trial in Multiple Presentations at Upcoming American Academy of Neurology Meeting

Content Relevant URLs by vBSEO 3.6.0 PL2